Sign Up to like & get
recommendations!
0
Published in 2019 at "Pharmaceutical Research"
DOI: 10.1007/s11095-019-2587-6
Abstract: BackgroundTofacitinib (Tofa) has been approved for moderately to severely active ulcerative colitis (UC). To improve its therapeutic efficacy and limit dose-dependent toxicity, we developed a macromolecular prodrug of Tofa (P-Tofa). If the prodrug design improves…
read more here.
Keywords:
tofa;
prodrug;
ulcerative colitis;
mice ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Pharmacological Reports"
DOI: 10.1007/s43440-019-00027-8
Abstract: Background and objective Acetyl CoA carboxylase (ACC) regulates the differentiation of Th1, Th2, Th17 cells and Treg cells, which play a critical role in airway inflammation of asthma. Here we investigated the role of ACC…
read more here.
Keywords:
tofa;
airway inflammation;
expression;
acetyl coa ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2865
Abstract: Background The amino-terminal fragment of the B-type natriuretic peptide prohormone (NT-proBNP) is a marker for functional cardiac impairment and is increased in heart disease with or without symptoms of congestive heart failure (CHF)1. Objectives To…
read more here.
Keywords:
none declared;
tofa;
probnp level;
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.920
Abstract: Tofacitinib (TOFA) is an oral, small molecule drug used for rheumatoid arthritis (RA) treatment and is prescribed alone or with methotrexate (MTX). We previously reported the similarity in retention between TOFA monotherapy and TOFA with…
read more here.
Keywords:
mtx;
arthritis;
discontinuation;
rheumatoid arthritis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "BioMed Research International"
DOI: 10.1155/2021/8877056
Abstract: Septic acute kidney injury (AKI) is the most common AKI syndrome in the intensive care unit (ICU), and it accounts for approximately half of AKI cases. Tofacitinib (TOFA) is a pan-Janus kinase (JAK) inhibitor that…
read more here.
Keywords:
jak;
kidney injury;
tofa;
aki ... See more keywords